<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Pediatric Post-Marketing Pharmacovigilance and Drug Utilization Reviews; Establishment of a Public Docket; Request for Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Pediatric Post-Marketing Pharmacovigilance and Drug Utilization Reviews; Establishment of a Public Docket; Request for Comments</h1>
    <p class="timestamp">Published: 2017-09-05 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is establishing a public docket to collect comments related to the pediatric post- marketing pharmacovigilance and drug utilization reviews of products posted between March 11, 2017, and September 12, 2017, on FDA's Web site but not presented at the September 12, 2017, Pediatric Advisory Committee (PAC) meeting. These reviews are intended to be available for review and comment by members of the PAC, interested parties (such as academic researchers, regulate...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2017-18690</p>
    <p><strong>Publication Date:</strong> 2017-09-05</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2017/09/05/2017-18690/pediatric-post-marketing-pharmacovigilance-and-drug-utilization-reviews-establishment-of-a-public">https://www.federalregister.gov/documents/2017/09/05/2017-18690/pediatric-post-marketing-pharmacovigilance-and-drug-utilization-reviews-establishment-of-a-public</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2017-18690</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
